SBRT for rising PSA after prostate removal
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a precise type of radiation (called SBRT) to the prostate bed for men whose PSA starts rising after prostate removal surgery. It aims to see if this targeted approach can effectively treat the recurrence without needing long-term hormone therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had surgery to remove your prostate (radical prostatectomy) as your first treatment for prostate cancer.
- Your PSA level after surgery is either still above 0.1 ng/mL, or has gone up on two or more blood tests.
- Your recent scans do not show any cancer spread to lymph nodes or other organs, and your PSA is currently at or below 2 ng/mL.
- You are in good overall health (able to carry out daily activities) and are 18 or older.
- You have not had radiation to the pelvis or certain other previous treatments for prostate cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a specialized PSMA PET scan to guide radiation can better treat prostate cancer that returns after prostate surgery. It targets the “prostate bed” area with a shorter, stronger radiation schedule (hypofractionated) to control rising PSA levels.
This study tests a tailored (personalized) radiation plan for men whose PSA (“prostate blood test”) rises after prostate surgery but who have no detectable spread on scans. It may help control cancer growth by targeting the right area based on your situation.
This trial compares two types of radiation for men who have had their prostate removed, to see if a dose tailored to their risk is just as good or better. It aims to reduce side effects while keeping the cancer from coming back.
This trial tests a type of focused radiation therapy for men with intermediate or high-risk prostate cancer that hasn't spread. It aims to improve outcomes by targeting the main tumor seen on MRI.
This trial tests giving early salvage radiotherapy (a type of radiation) to men whose PSA rises after prostate removal, but before it shows up on scans. It aims to see if starting treatment early, based on molecular markers, is more effective than waiting.
This trial tests a newer, more precise radiation treatment that gives a higher dose to the main tumor while keeping radiation to the rest of the prostate the same. It is for men with intermediate- or high-risk prostate cancer who haven't had prior prostate radiation or removal.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.